EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (AMEX & TSX: NBY, http://novabaypharma.com), a biopharmaceutical company developing products for the treatment or prevention of a wide range of bacterial and viral infections, presented at the 20th Annual Roth Capital Partners OC Growth Conference on February 21, 2008. A video excerpt of the company’s presentation was featured on MSN Money.
